Report cover image

Global Influenza Vaccine Market Insights, Forecast to 2028

Publisher QYResearch Group
Published Apr 01, 2022
Length 158 Pages
SKU # QYR17072470

Description

Global Influenza Vaccine Market Insights, Forecast to 2028

Summary

Market Analysis and Insights: Global Influenza Vaccine Market
Due to the COVID-19 pandemic, the global Influenza Vaccine market size is estimated to be worth US$ 8036 million in 2022 and is forecast to a readjusted size of US$ 10952 million by 2028 with a CAGR of 5.3% during the review period.

The global key manufacturers of Influenza Vaccine include CSL, GSK, Sanofi, Viatris, Hualan Bio, AstraZeneca, Changchun Institute of Biological, etc. In 2021, the global top five players have a share approximately 85.04% in terms of revenue.

Global Influenza Vaccine Scope and Segment
Influenza Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Influenza Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type, and by Application for the period 2017-2028.

By Company
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
BCHT
Jiangsu GDK
KM Biologics

Segment by Type
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine

Segment by Application
For Children (6 months to 3 years)
For Adults and Children over 3 years

Segment by Region
North America
U.S.
Canada
Mexico

Asia-Pacific
China
Japan
South Korea
India
Australia
Southeast Asia

Europe
Germany
France
U.K.
Italy
Russia

South America
Brazil

Middle East & Africa
Middle East
Africa

Table of Contents

158 Pages
1 STUDY COVERAGE
1.1 Influenza Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Influenza Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Trivalent Influenza Vaccine
1.2.3 Quadrivalent Influenza Vaccine
1.3 Market by Application
1.3.1 Global Influenza Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 For Children (6 months to 3 years)
1.3.3 For Adults and Children over 3 years
1.4 Study Objectives
1.5 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Influenza Vaccine Sales Estimates and Forecasts 2017-2028
2.2 Global Influenza Vaccine Revenue Estimates and Forecasts 2017-2028
2.3 Global Influenza Vaccine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Influenza Vaccine Sales by Region
2.4.1 Global Influenza Vaccine Sales by Region (2017-2022)
2.4.2 Global Sales Influenza Vaccine by Region (2023-2028)
2.5 Global Influenza Vaccine Revenue by Region
2.5.1 Global Influenza Vaccine Revenue by Region (2017-2022)
2.5.2 Global Influenza Vaccine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 South America
2.10 Middle East & Africa
3 COMPETITION BY MANUFACTURERS
3.1 Global Influenza Vaccine Sales by Manufacturers
3.1.1 Global Influenza Vaccine Sales by Manufacturers (2020-2022)
3.1.2 Global Influenza Vaccine Sales Market Share by Manufacturers (2020-2022)
3.1.3 Global Top Largest Manufacturers of Influenza Vaccine in 2021
3.2 Global Influenza Vaccine Revenue by Manufacturers
3.2.1 Global Influenza Vaccine Revenue by Manufacturers (2020-2022)
3.2.2 Global Influenza Vaccine Revenue Market Share by Manufacturers (2020-2022)
3.2.3 Global Top Companies by Influenza Vaccine Revenue in 2021
3.3 Global Influenza Vaccine Sales Price by Manufacturers (2020-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Influenza Vaccine by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Influenza Vaccine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 MARKET SIZE BY TYPE
4.1 Global Influenza Vaccine Sales by Type
4.1.1 Global Influenza Vaccine Historical Sales by Type (2017-2022)
4.1.2 Global Influenza Vaccine Forecasted Sales by Type (2023-2028)
4.1.3 Global Influenza Vaccine Sales Market Share by Type (2017-2028)
4.2 Global Influenza Vaccine Revenue by Type
4.2.1 Global Influenza Vaccine Historical Revenue by Type (2017-2022)
4.2.2 Global Influenza Vaccine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Influenza Vaccine Revenue Market Share by Type (2017-2028)
4.3 Global Influenza Vaccine Price by Type
4.3.1 Global Influenza Vaccine Price by Type (2017-2022)
4.3.2 Global Influenza Vaccine Price Forecast by Type (2023-2028)
5 MARKET SIZE BY APPLICATION
5.1 Global Influenza Vaccine Sales by Application
5.1.1 Global Influenza Vaccine Historical Sales by Application (2017-2022)
5.1.2 Global Influenza Vaccine Forecasted Sales by Application (2023-2028)
5.1.3 Global Influenza Vaccine Sales Market Share by Application (2017-2028)
5.2 Global Influenza Vaccine Revenue by Application
5.2.1 Global Influenza Vaccine Historical Revenue by Application (2017-2022)
5.2.2 Global Influenza Vaccine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Influenza Vaccine Revenue Market Share by Application (2017-2028)
5.3 Global Influenza Vaccine Price by Application
5.3.1 Global Influenza Vaccine Price by Application (2017-2022)
5.3.2 Global Influenza Vaccine Price Forecast by Application (2023-2028)
6 NORTH AMERICA
6.1 North America Influenza Vaccine Market Size by Type
6.1.1 North America Influenza Vaccine Sales by Type (2017-2028)
6.1.2 North America Influenza Vaccine Revenue by Type (2017-2028)
6.2 North America Influenza Vaccine Market Size by Application
6.3 North America Influenza Vaccine Sales by Country
6.3.1 North America Influenza Vaccine Sales by Country (2017-2028)
6.3.2 North America Influenza Vaccine Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
7 EUROPE
7.1 Europe Influenza Vaccine Market Size by Type
7.1.1 Europe Influenza Vaccine Sales by Type (2017-2028)
7.1.2 Europe Influenza Vaccine Revenue by Type (2017-2028)
7.2 Europe Influenza Vaccine Market Size by Application
7.3 Europe Influenza Vaccine Market Size by Country
7.3.1 Europe Influenza Vaccine Sales by Country (2017-2028)
7.3.2 Europe Influenza Vaccine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 ASIA PACIFIC
8.1 Asia Pacific Influenza Vaccine Market Size by Type
8.1.1 Asia Pacific Influenza Vaccine Sales by Type (2017-2028)
8.1.2 Asia Pacific Influenza Vaccine Revenue by Type (2017-2028)
8.2 Asia Pacific Influenza Vaccine Market Size by Application
8.3 Asia Pacific Influenza Vaccine Market Size by Region
8.3.1 Asia Pacific Influenza Vaccine Sales by Region (2017-2028)
8.3.2 Asia Pacific Influenza Vaccine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Southeast Asia
9 SOUTH AMERICA
9.1 South America Influenza Vaccine Market Size by Type
9.1.1 South America Influenza Vaccine Sales by Type (2017-2028)
9.1.2 South America Influenza Vaccine Revenue by Type (2017-2028)
9.2 South America Influenza Vaccine Market Size by Application
9.3 South America Influenza Vaccine Market Size by Country
9.3.1 South America Influenza Vaccine Sales by Country (2017-2028)
9.3.2 South America Influenza Vaccine Revenue by Country (2017-2028)
9.3.3 Brazil
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Influenza Vaccine Market Size by Type
10.1.1 Middle East and Africa Influenza Vaccine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Influenza Vaccine Revenue by Type (2017-2028)
10.2 Middle East and Africa Influenza Vaccine Market Size by Application
10.3 Middle East and Africa Influenza Vaccine Market Size by Country
10.3.1 Middle East and Africa Influenza Vaccine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Influenza Vaccine Revenue by Country (2017-2028)
10.3.3 Middle East
10.3.4 Africa
11 CORPORATE PROFILE
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Overview
11.1.3 Sanofi Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2022)
11.1.4 Sanofi Influenza Vaccine Product Introduction
11.1.5 Sanofi Recent Developments
11.2 CSL
11.2.1 CSL Corporation Information
11.2.2 CSL Overview
11.2.3 CSL Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2022)
11.2.4 CSL Influenza Vaccine Product Introduction
11.2.5 CSL Recent Developments
11.3 GSK
11.3.1 GSK Corporation Information
11.3.2 GSK Overview
11.3.3 GSK Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2022)
11.3.4 GSK Influenza Vaccine Product Introduction
11.4 Viatris
11.4.1 Viatris Corporation Information
11.4.2 Viatris Overview
11.4.3 Viatris Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2022)
11.4.4 Viatris Influenza Vaccine Product Introduction
11.4.5 Viatris Recent Developments
11.5 AstraZeneca
11.5.1 AstraZeneca Corporation Information
11.5.2 AstraZeneca Overview
11.5.3 AstraZeneca Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2022)
11.5.4 AstraZeneca Influenza Vaccine Product Introduction
11.5.5 AstraZeneca Recent Developments
11.6 Hualan Bio
11.6.1 Hualan Bio Corporation Information
11.6.2 Hualan Bio Overview
11.6.3 Hualan Bio Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2022)
11.6.4 Hualan Bio Influenza Vaccine Product Introduction
11.7 Changchun Institute of Biological
11.7.1 Changchun Institute of Biological Corporation Information
11.7.2 Changchun Institute of Biological Overview
11.7.3 Changchun Institute of Biological Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2022)
11.7.4 Changchun Institute of Biological Influenza Vaccine Product Introduction
11.7.5 Changchun Institute of Biological Recent Developments
11.8 Sinovac
11.8.1 Sinovac Corporation Information
11.8.2 Sinovac Overview
11.8.3 Sinovac Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2022)
11.8.4 Sinovac Influenza Vaccine Product Introduction
11.8.5 Sinovac Recent Developments
11.9 BCHT
11.9.1 BCHT Corporation Information
11.9.2 BCHT Overview
11.9.3 BCHT Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2022)
11.9.4 BCHT Influenza Vaccine Product Introduction
11.9.5 BCHT Recent Developments
11.10 Jiangsu GDK
11.10.1 Jiangsu GDK Corporation Information
11.10.2 Jiangsu GDK Overview
11.10.3 Jiangsu GDK Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2022)
11.10.4 Jiangsu GDK Influenza Vaccine Product Introduction
11.11 KM Biologics
11.11.1 KM Biologics Corporation Information
11.11.2 KM Biologics Overview
11.11.3 KM Biologics Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2022)
11.11.4 KM Biologics Influenza Vaccine Product Introduction
11.11.5 KM Biologics Recent Developments
12 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
12.1 Influenza Vaccine Industry Chain Analysis
12.2 Influenza Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Influenza Vaccine Production Mode & Process
12.4 Influenza Vaccine Sales and Marketing
12.4.1 Influenza Vaccine Sales Channels
12.4.2 Influenza Vaccine Distributors
12.5 Influenza Vaccine Customers
13 INFLUENZA VACCINE MARKET DYNAMICS
13.1.1 Influenza Vaccine Industry Trends
13.1.2 Influenza Vaccine Market Drivers
13.1.3 Influenza Vaccine Market Challenges
13.1.4 Influenza Vaccine Market Restraints
14 KEY FINDINGS IN THE GLOBAL INFLUENZA VACCINE STUDY
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Influenza Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Quadrivalent Influenza Vaccine
Table 3. Global Influenza Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 4. Global Influenza Vaccine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Influenza Vaccine Sales by Region (2017-2022) & (M Doses)
Table 6. Global Influenza Vaccine Sales Market Share by Region (2017-2022)
Table 7. Global Influenza Vaccine Sales by Region (2023-2028) & (M Doses)
Table 8. Global Influenza Vaccine Sales Market Share by Region (2023-2028)
Table 9. Global Influenza Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 10. Global Influenza Vaccine Revenue Market Share by Region (2017-2022)
Table 11. Global Influenza Vaccine Revenue by Region (2023-2028) & (US$ Million)
Table 12. Global Influenza Vaccine Revenue Market Share by Region (2023-2028)
Table 13. Global Influenza Vaccine Sales by Manufacturers (2020-2022) & (M Doses)
Table 14. Global Influenza Vaccine Sales Share by Manufacturers (2020-2022)
Table 15. Global Influenza Vaccine Revenue by Manufacturers (2020-2022) & (US$ Million)
Table 16. Global Influenza Vaccine Revenue Market Share by Manufacturers (2020-2022)
Table 17. Influenza Vaccine Price by Manufacturers (2020-2022) & (USD/Doses)

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us